Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Compass Therapeutics Q2 EPS $(0.08) Up From $(1.07) YoY

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.
byBenzinga Newsdesk
August 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts